tiprankstipranks
Advertisement
Advertisement

CTXR Stock Latest News

Citius Oncology reports strong LYMPHIR U.S. launch momentum
Company AnnouncementsCitius Oncology reports strong LYMPHIR U.S. launch momentum
21h ago
8K
CTXR
Citius Oncology reports availability of Lymphir in institutions grew 78% in Q3
PremiumThe Fly
Citius Oncology reports availability of Lymphir in institutions grew 78% in Q3
21h ago
CTOR
CTXR
Citius Oncology provides update on commercial launch of Lymphir
PremiumThe Fly
Citius Oncology provides update on commercial launch of Lymphir
16d ago
CTOR
CTXR
Citius Highlights LYMPHIR Combo Data in Gynecologic Cancers
PremiumCompany Announcements
Citius Highlights LYMPHIR Combo Data in Gynecologic Cancers
2M ago
8K
CTXR
Citius Oncology highlights Phase 1 data evaluating Lymphir at ASCO
PremiumThe Fly
Citius Oncology highlights Phase 1 data evaluating Lymphir at ASCO
2M ago
CTOR
CTXR
CTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts
PremiumWeekend UpdatesCTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts
3M ago
AMT
CTMX
Citius Pharmaceuticals files to sell 5.43M shares of common stock for holders
Premium
The Fly
Citius Pharmaceuticals files to sell 5.43M shares of common stock for holders
3M ago
CTXR
Citius Pharmaceuticals assumed with a Buy at H.C. Wainwright
Premium
The Fly
Citius Pharmaceuticals assumed with a Buy at H.C. Wainwright
3M ago
CTXR
Citius Pharmaceuticals Amends Promissory Note to Enhance Flexibility
PremiumCompany Announcements
Citius Pharmaceuticals Amends Promissory Note to Enhance Flexibility
3M ago
8K
CTXR
Citius Expands LYMPHIR Access with First European Shipment
PremiumCompany Announcements
Citius Expands LYMPHIR Access with First European Shipment
3M ago
8K
CTXR
Citius Oncology announces initial shipment of LYMPHIR to Europe
PremiumThe Fly
Citius Oncology announces initial shipment of LYMPHIR to Europe
3M ago
CTOR
CTXR
Citius Pharmaceuticals Raises $5 Million in Securities Offering
PremiumCompany Announcements
Citius Pharmaceuticals Raises $5 Million in Securities Offering
3M ago
8K
CTXR
Citius Pharmaceuticals announces $5M registered direct offering priced ATM
PremiumThe FlyCitius Pharmaceuticals announces $5M registered direct offering priced ATM
3M ago
CTXR
Citius Pharmaceuticals Announces 2026 Annual Stockholder Meeting Results
Premium
Company Announcements
Citius Pharmaceuticals Announces 2026 Annual Stockholder Meeting Results
4M ago
8K
CTXR
Citius Oncology advances LYMPHIR launch and global expansion
Premium
Company Announcements
Citius Oncology advances LYMPHIR launch and global expansion
4M ago
8K
CTXR
Citius Highlights Positive LYMPHIR Phase 1 Gynecologic Cancer Data
PremiumCompany Announcements
Citius Highlights Positive LYMPHIR Phase 1 Gynecologic Cancer Data
5M ago
8K
CTXR
Citius Oncology Reports Positive LYMPHIR Phase 1 CAR-T Data
PremiumCompany Announcements
Citius Oncology Reports Positive LYMPHIR Phase 1 CAR-T Data
5M ago
8K
CTXR
Citius Pharmaceuticals receives $3.8M through NJEDA program
PremiumThe Fly
Citius Pharmaceuticals receives $3.8M through NJEDA program
5M ago
CTXR
Citius Pharmaceuticals Posts First Revenue Amid Listing Risk
PremiumCompany Announcements
Citius Pharmaceuticals Posts First Revenue Amid Listing Risk
6M ago
8K
CTXR
Citius Oncology reports Q1 EPS (6c) vs. (9c) last year
PremiumThe FlyCitius Oncology reports Q1 EPS (6c) vs. (9c) last year
6M ago
CTOR
CTXR
Citius Pharmaceuticals reports $3.9M in revenue following launch of Lymphir
Premium
The Fly
Citius Pharmaceuticals reports $3.9M in revenue following launch of Lymphir
6M ago
CTOR
CTXR
Citius Pharmaceuticals reports Q1 EPS (41c) vs. ($1.30) last year
Premium
The Fly
Citius Pharmaceuticals reports Q1 EPS (41c) vs. ($1.30) last year
6M ago
CTOR
CTXR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >